Refine
Has Fulltext
- yes (831) (remove)
Year of publication
- 2012 (831) (remove)
Document Type
- Journal article (373)
- Doctoral Thesis (373)
- Complete part of issue (48)
- Preprint (8)
- Report (8)
- Book (4)
- Book article / Book chapter (4)
- Jahresbericht (3)
- Review (3)
- Conference Proceeding (2)
Keywords
- Würzburg (50)
- Universität (46)
- Wuerzburg (44)
- Wurzburg (44)
- Medizin (43)
- University (42)
- hadron-hadron scattering (15)
- Biologie (13)
- Psychologie (12)
- melanoma (10)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (94)
- Universität Würzburg (47)
- Graduate School of Life Sciences (43)
- Fakultät für Physik und Astronomie (39)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (28)
- Medizinische Klinik und Poliklinik I (28)
- Institut für Psychologie (27)
- Physikalisches Institut (27)
- Neurologische Klinik und Poliklinik (25)
- Institut für Molekulare Infektionsbiologie (24)
Sonstige beteiligte Institutionen
Dendritic cells (DCs) are major players in the control of adaptive tolerance and immunity. Therefore, their specific generation and adoptive transfer into patients or their in vivo targeting is attractive for clinical applications. While injections of mature immunogenic DCs are tested in clinical trials, tolerogenic DCs still are awaiting this step. Besides the tolerogenic potential of immature DCs, also semi-mature DCs can show tolerogenic activity but both types also bear unfavorable features. Optimal tolerogenic DCs, their molecular tool bar, and their use for specific diseases still have to be defined. Here, the usefulness of in vitro generated and adoptively transferred semi-mature DCs for tolerance induction is outlined. The in vivo targeting of semi-mature DCs as represented by steady state migratory DCs are discussed for treatment of autoimmune diseases and allergies. First clinical trials with transcutaneous allergen application may point to their therapeutic use in the future.